Neogenomics (NEO) Assets Average (2011 - 2026)

Neogenomics has reported Assets Average for 16 years, with the latest figure at $1.4 billion in Q1 2026.

• For the quarter ending Q1 2026, Assets Average fell 16.46% year-over-year to $1.4 billion; the trailing twelve-month figure through Mar 2026 stood at $1.4 billion (down 16.46% YoY), and the FY2025 full-year result was $1.5 billion, down 9.68% from the prior year.
• Assets Average for Q1 2026 stood at $1.4 billion, down from $1.4 billion in the prior quarter.
• The five-year high for Assets Average was $1.8 billion in Q1 2022, with the low at $1.4 billion in Q1 2026.
• Historically, Assets Average has averaged $1.6 billion across 5 years, with a median of $1.7 billion in 2024.
• Annual changes were most pronounced in 2022 — Assets Average jumped 143.47% — and 2025, when it retreated 16.61%.
• Neogenomics' Assets Average stood at $1.7 billion in 2022, then declined by 3.89% to $1.7 billion in 2023, then retreated by 2.39% to $1.6 billion in 2024, then dropped by 16.61% to $1.4 billion in 2025, then decreased by 1.03% to $1.4 billion in 2026.
• The last three Assets Average figures came in at $1.4 billion (Q1 2026), $1.4 billion (Q4 2025), and $1.4 billion (Q3 2025), per Business Quant data.